Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To investigate whether preoperative serum anti-mullerian hormone (AMH) levels are lower in women with ovarian endometrioma and in women with mature cystic teratoma of the ovaries. Materials and Methods: In a tertiary university hospital, a retrospective case-control study was performed. Serum AMH levels between an advanced (stage III and IV) endometrioma group (n=102) and an age- and body mass index (BMI)-matched control group were compared. Serum AMH levels between an ovarian mature cystic teratoma group (n=48) and age- and BMI-matched controls were also compared. Results: Absolute serum AMH and multiples of the median for AMH (AMH-MoM) relevant to Korean standards were lower in the endometrioma group than controls, but this was not statistically significant (mean±SEM, 2.9±0.3 ng/mL vs. 3.3±0.3 ng/mL, p=0.28 and 1.3±0.1 vs. 1.6±0.1, p=0.29, respectively). Specifically, the stage IV endometriosis group (n=51) exhibited significantly lower serum AMH and AMH-MoM (2.1±0.3 vs. 3.1±0.4 ng/mL, p=0.02 and 1.1±0.1 vs. 1.7±0.2, p=0.03, respectively). Serum AMH and AMH-MoM levels were similar between stage III endometriosis and controls (3.7±0.5 vs. 3.4±0.5 ng/mL and 1.6±0.2 vs. 1.5±0.2, respectively), as well as between the mature cystic teratoma group and controls (4.0±0.5 ng/mL vs. 4.0±0.5 ng/mL and 1.6±0.2 vs. 1.6±0.3, respectively). Interestingly, AMH-MoM level was negatively correlated with endometriosis score with statistical significance (r2=0.13, p<0.01). Conclusion: In women with advanced ovarian endometrioma, preoperative serum AMH values tended to be lower than those for age and BMI-matched controls. Notably,stage IV endometrioma appeared to be closely associated with decreased ovarian reserve, even before operation. Clinicians should keep this information in mind before undertaking surgery of ovarian endometrioma.
Abstract
Purpose: To investigate whether preoperative serum anti-mullerian hormone (AMH) levels are lower in women with ovarian endometrioma and in women with mature cystic teratoma of the ovaries. Materials and Methods: In a tertiary university hospital, a retrospective case-control study was performed. Serum AMH levels between an advanced (stage III and IV) endometrioma group (n=102) and an age- and body mass index (BMI)-matched control group were compared. Serum AMH levels between an ovarian mature cystic teratoma group (n=48) and age- and BMI-matched controls were also compared. Results: Absolute serum AMH and multiples of the median for AMH (AMH-MoM) relevant to Korean standards were lower in the endometrioma group than controls, but this was not statistically significant (mean±SEM, 2.9±0.3 ng/mL vs. 3.3±0.3 ng/mL, p=0.28 and 1.3±0.1 vs. 1.6±0.1, p=0.29, respectively). Specifically, the stage IV endometriosis group (n=51) exhibited significantly lower serum AMH and AMH-MoM (2.1±0.3 vs. 3.1±0.4 ng/mL, p=0.02 and 1.1±0.1 vs. 1.7±0.2, p=0.03, respectively). Serum AMH and AMH-MoM levels were similar between stage III endometriosis and controls (3.7±0.5 vs. 3.4±0.5 ng/mL and 1.6±0.2 vs. 1.5±0.2, respectively), as well as between the mature cystic teratoma group and controls (4.0±0.5 ng/mL vs. 4.0±0.5 ng/mL and 1.6±0.2 vs. 1.6±0.3, respectively). Interestingly, AMH-MoM level was negatively correlated with endometriosis score with statistical significance (r2=0.13, p<0.01). Conclusion: In women with advanced ovarian endometrioma, preoperative serum AMH values tended to be lower than those for age and BMI-matched controls. Notably,stage IV endometrioma appeared to be closely associated with decreased ovarian reserve, even before operation. Clinicians should keep this information in mind before undertaking surgery of ovarian endometrioma.
참고문헌 (30)
- Ozkan S, "Endometriosis and infertility: epidemiology and evidence-based treatments", Ann N Y Acad Sci, 1127, pp.92~100 (2008)
- Verkauf BS, "Incidence, symptoms, and signs of endometriosis in fertile and infertile women", J Fla Med Assoc, 74, pp.671~675 (1987)
- Navarro J, "How does endometriosis affect infertility?", Obstet Gynecol Clin North Am, 30, pp.181~192 (2003)
- Lessey BA, "Implantation defects in infertile women with endometriosis", Ann N Y Acad Sci, 955, pp.265~280 (2002)
- Barnhart K, "Effect of endometriosis on in vitro fertilization", Fertil Steril, 77, pp.1148~1155 (2002)
- Wright VC, "Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance--United States, 2005", MMWR Surveill Summ, 57, pp.1~23 (2008)
- Kitajima M, "Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis", Fertil Steril, 96, pp.685~691 (2011)
- Shebl O, "Anti muellerian hormone serum levels in women with endometriosis: a case-control study", Gynecol Endocrinol, 25, pp.713~716 (2009)
- Campos CS, "Follicular-fluid anti-Müllerian hormone concentration is similar in patients with endometriosis compared with non-endometriotic patients", Reprod Biomed Online, 21, pp.470~473 (2010)
- Chang HJ, "Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels", Fertil Steril, 94, pp.343~349 (2010)
- Iwase A, "Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve", Fertil Steril, 94, pp.2846~2849 (2010)
- Kitajima M, "Changes in serum anti-Müllerian hormone levels may predict damage to residual normal ovarian tissue after laparoscopic surgery for women with ovarian endometrioma", Fertil Steril, 95, pp.2589~2591 (2011)
- Kim MJ, "Clinical characteristics of ovarian teratoma: age-focused retrospective analysis of 580 cases", Am J Obstet Gynecol, 205(32), pp.e1~e4 (2011)
- Lakkis WG, "Benign cystic teratoma of the ovary: a 6-year review", Can J Surg, 28, pp.444~446 (1985)
- Parazzini F, "Risk factors for benign ovarian teratomas", Br J Cancer, 71, pp.644~646 (1995)
- Lee JY, "Age-related distributions of anti-Müllerian hormone level and anti-Müllerian hormone models", Acta Obstet Gynecol Scand, 91, pp.970~975 (2012)
- de Vet A, "Antimüllerian hormone serum levels: a putative marker for ovarian aging", Fertil Steril, 77, pp.357~362 (2002)
- Kunt C, "Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization", Arch Gynecol Obstet, 283, pp.1415~1421 (2011)
- Muttukrishna S, "Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?", BJOG, 112, pp.1384~1390 (2005)
- Bungum L, "Circadian variation in concentration of anti-Müllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels", Hum Reprod, 26, pp.678~684 (2011)
- La Marca A, "Serum anti-Mullerian hormone throughout the human menstrual cycle", Hum Reprod, 21, pp.3103~3107 (2006)
- Freeman EW, "Association of anti-mullerian hormone levels with obesity in late reproductive-age women", Fertil Steril, 87, pp.101~106 (2007)
- Osuga Y, "Role of laparoscopy in the treatment of endometriosis-associated infertility", Gynecol Obstet Invest, 53(1), pp.33~39 (2002)
- Arici A, "The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program", Fertil Steril, 65, pp.603~607 (1996)
- Azem F, "Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility", Fertil Steril, 72, pp.1107~1109 (1999)
- Al-Azemi M, "Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis", Hum Reprod, 15, pp.72~75 (2000)
- Díaz I, "Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study", Fertil Steril, 74, pp.31~34 (2000)
- Falconer H, "IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone", Reprod Biomed Online, 18, pp.582~588 (2009)
- Halis G, "Endometriosis and inflammation in infertility", Ann N Y Acad Sci, 1034, pp.300~315 (2004)
- Lee KS, "Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality", J Assist Reprod Genet, 17, pp.222~228 (2000)